03.10.2023 Views

Newsletter_10-2023_EN

Transform your PDFs into Flipbooks and boost your revenue!

Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.

<strong>EN</strong> <strong>10</strong>/23<br />

Safeguarding hospitals<br />

and healthcare centers<br />

with vaporized hydrogen<br />

peroxide


Safeguarding hospitals and healthcare<br />

centers with vaporized hydrogen peroxide<br />

Iacobus is the Greek variant of the Hebrew word meaning “held by the heel”, but the original definition is thought to come<br />

from an Aramaic phrase for “may God protect.” Founded in 2014 in Łódź, Poland, Iacobus Sp z.o.o offers decontamination<br />

services and equipment. Iacobus also services and sells medical devices and is an authorized dealer of products from CLEA-<br />

MIX, K<strong>EN</strong> instrument washers, TBT medical, MDG Engineering srl, CASPR Group.<br />

Piotr Węgier, lead service engineer, has been with Iacobus since its<br />

creation. “We sell and maintain devices for disinfection, sterilization<br />

and bio-decontamination,” says Węgier. “We were three engineers<br />

with experience in servicing medical devices and systems for sterilization<br />

and bio-decontamination, so we went into business. Our<br />

main focus is now healthcare, pharmaceutical production, and food<br />

production.”<br />

Iacobus often performs bio-decontamination in hospitals in environments<br />

like patient rooms and operating suites. Because hospital<br />

beds are always in demand, the duration of room bio-decontamination<br />

is crucial.<br />

“The goal in hospitals is always to perform the bio-decontamination<br />

as quickly as possible because the beds are always needed,”<br />

says Węgier. “Ideally, we want to perform a full bio-decontamination<br />

with vaporized hydrogen peroxide, but because time is so critical,<br />

other types of decontamination are popular. We try to educate facility<br />

managers on why vaporized hydrogen peroxide processes are so<br />

effective, to help them choose the best method. There are decontamination<br />

service providers on the market who offer aerosol disinfection<br />

or ozone generators and similar systems. Unfortunately, the<br />

brochures for these methods may oversell the actual results.”<br />

Because Iacobus provides equipment to organizations that perform<br />

regular decontamination, they also provide training in the use<br />

of vH2O2 bio-decontamination equipment.<br />

“The method used is important, especially in vaporized hydrogen<br />

peroxide processes,” says Węgier. “With vaporized hydrogen<br />

peroxide you use a high-concentration hydrogen peroxide solution.<br />

The liquid is converted to the gas form. The heat required to vaporize<br />

hydrogen peroxide is greater than that needed to vaporize water.<br />

Air that contains vaporized hydrogen peroxide will condense sooner.<br />

The condensate that is produced can have high parts per million of<br />

vaporized H2O2 vapor. This may cause some damage to the surfaces,<br />

so care must be taken.”<br />

“This is one of the main advantages of doing vH2O2 decontamination<br />

with the Vaisala HPP270 sensor. The sensor gives real-time<br />

information so you know when the condensation point is close.”<br />

Piotr Węgier, Iacobus Sp. z.o.o<br />

One of the vapor generators Iacobus uses is the Cleamix portable<br />

vapor generator, which comes equipped with Vaisala’s HPP270 vaporized<br />

hydrogen peroxide probe. The probes provide various parameter<br />

measurements, including: hydrogen peroxide vapor, temperature,<br />

and humidity (as relative saturation and relative humidity), dew<br />

point, and vapor pressure. The HPP270 probes can be integrated<br />

with a vapor generator or control system.<br />

“I learned about the Cleamix portable generators from a Vaisala<br />

webinar,” says Węgier. “The product interested us due to the size<br />

and design; it’s the size of a suitcase. Years of feedback from our customers<br />

told us that the size of many vapor generators was the biggest<br />

disadvantage in the process. It is time consuming to get a machine<br />

and all necessary equipment from the storage location to the target<br />

area for decontamination.<br />

„The portability of the Cleamix vapor generator was a great benefit<br />

and we find that the output is enough for most applications we<br />

do. Often the areas that are being decontaminated are less than <strong>10</strong>0<br />

m2. We were also very interested in the HPP270 sensor because it<br />

provided possibilities for tests and calibrations of other sensors.”<br />

Along with patient rooms, hospitals bio-decontaminate procedural<br />

rooms and operating theatres. These rooms are often sites of<br />

increased risk due to open wounds and body fluids. Today there is<br />

an increasing global concern over multidrug-resistant organisms<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 2/28


(MDROs), many of which can persist despite other types of cleaning,<br />

such as routine terminal cleaning. Decontamination with vaporized<br />

hydrogen peroxide in addition to terminal cleaning can significantly<br />

reduce the risk of cross-contamination.<br />

However, operating suites can have challenges in bio-decontamination<br />

processes that involve vapor fumigation. “In operating<br />

theatres there is sometimes the issue of not being able to turn off<br />

the ventilation system,” says Węgier. “In one case, we had a room<br />

which had routinely been disinfected with aerosol machines. We<br />

were called to do a vH2O2 bio-decontamination when their aerosol<br />

equipment broke down. During the process, we noticed that the ventilation<br />

system was pulling the H2O2 vapor out of the room.<br />

“This told us that the room may not have been properly decontaminated<br />

before, because the ventilation would likely have pulled a lot<br />

of the airborne aerosolized disinfectant out of the room. The Vaisala<br />

HPP270 sensor, with its real-time measurements, showed us what<br />

was happening during decontamination and allowed us to identity<br />

the issue.”<br />

The coronavirus pandemic initiated stricter disinfection and<br />

decontamination protocols to stop the transmission of COVID-19<br />

between patients in hospitals. With the COVID-19 pandemic, as<br />

well as increasing anti-microbial resistance in other pathogens,<br />

bio-decontamination that is streamlined and effective is becoming<br />

critical for public safety. Vaporized hydrogen peroxide systems that<br />

are equipped with real-time sensors can efficiently safeguard public<br />

areas where human health is most at risk.<br />

“Since the pandemic began, we’ve seen customers using their<br />

vaporized hydrogen peroxide systems every day, even several times<br />

per day,” says Węgier. “Time was always a major challenge in decontamination,<br />

but now it’s even more important to decontaminate effectively<br />

and quickly.<br />

“This year we saw outbreaks in hospitals where all patients on a<br />

ward were positive for coronavirus. In these cases, the entire ward<br />

had to be decontaminated as quickly as possible. Having our portable<br />

vapor generators with the Vaisala probe helped us make these<br />

wards safer for personnel and patients.”<br />

October <strong>2023</strong><br />

Dear cleanroom professionals ,<br />

We have known for some time that<br />

Germany is not a pony farm. There are<br />

many reasons for this. These include,<br />

in particular, constantly tightened<br />

specifications and legal regulations.<br />

This is the subject of our cover story in<br />

the German newsletter. The cover story<br />

of the English newsletter is also about the<br />

health sector. Other interesting articles<br />

deal with the following topics, among<br />

others:<br />

> Safeguarding hospitals and healthcare<br />

centers with vaporized hydrogen<br />

peroxide<br />

> Vial filling: Integrated line concept<br />

> Cyto-Facto Inc.: Advancing<br />

cell & gene therapies, providing<br />

the promise of health<br />

> Receiving MHRA approval<br />

> Winning two of this year’s German<br />

Packaging Awards<br />

> Syntegon at CPHI Barcelona: New<br />

solutions for small and micro batches<br />

> High-End Humidity and Temperature<br />

Sensor for Highest Demands<br />

> Long Lasting Labeling Solution for<br />

Laboratory Chair Manufacturer<br />

> Hygiene with precision<br />

With kind regards<br />

Reinhold Schuster<br />

Vaisala GmbH<br />

Rheinwerkallee 2<br />

D 53227 Bonn<br />

Telefon: +49 228 2497<strong>10</strong><br />

Telefax: +49 228 2497111<br />

eMail: vertrieb@vaisala.com<br />

Internet: http://www.vaisala.de<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 3/28


Alcami’s new ARF isolator line is up and running, allowing the company to more than double<br />

the daily production volume in Charleston.<br />

Vial filling: Integrated line<br />

concept from Syntegon<br />

for CDMO Alcami<br />

Autor: Stefan Schuh<br />

Success is a real pacemaker: once it manifests itself as a major milestone like a portfolio expansion or a sales target, the<br />

search for the next growth opportunity has already begun. The US-based company Alcami Corporation has done so time<br />

and again. As a successful CDMO for the pharmaceutical and biotech industries, Alcami has confirmed its market position<br />

through constant adaptations and innovations. One of the latest saw Syntegon support the company with a flexible turnkey<br />

vial filling line for increased output.<br />

675,000 square feet is a lot of space – enough to build a strong presence across North America. The impressive<br />

number represents the total area operated by the Alcami Corporation, a major pharma and biopharma<br />

CDMO. With its headquarters in Wilmington, North Carolina, the company runs facilities across<br />

the country, including scientific campuses in Charleston, South Carolina, Research Triangle Park, North<br />

Carolina, St. Louis, Missouri, and multiple locations near Boston Massachusetts. The sites provide the<br />

much-needed flexibility to serve pharmaceutical and biotech companies of all sizes.<br />

The latter are as diverse as Alcami’s vast network and related services: from customized solutions for<br />

analytical development to clinical and commercial sterile fill-finish and oral solid dosage manufacturing,<br />

the CDMO covers a wealth of steps along the pharmaceutical value chain. Its comprehensive portfolio<br />

makes it one of the country’s few standalone full contract service providers, including packaging, microbiology,<br />

environmental monitoring, and pharmaceutical support services.<br />

Pushing the boundaries<br />

Stefan Schuh<br />

This strong market position didn’t come overnight: continuous portfolio expansions and a growing domestic<br />

presence have strongly contributed to the corporation’s current success – and keep the company<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 4/28


The line comes with proven isolator technology from Syntegon,<br />

which effectively separates production areas and personnel, thus<br />

contributing to the highest hygiene and safety standards.<br />

As the line’s centerpiece, the filling and closing platform ARF<br />

offers a versatile solution on a smaller footprint. For Alcami, the<br />

major benefit of the ARF is the machine’s format flexibility.<br />

busy in pushing its own boundaries. For over 40 years, Alcami has<br />

taken pride in advancing products for its customers. This has led to<br />

steady growth and increased demand, requiring a significant expansion<br />

of their vial filling capacities for injectable medicines.<br />

Alcami typically provides sterile filling operations for liquid<br />

and lyophilized products for a broad range of customers in a variety<br />

of containers, including 1 to 3 milliliter prefilled syringes and<br />

2 to 50 milliliter vials. While the two campuses in the Carolinas<br />

provide redundancy and additional capacity, the Charleston site<br />

required additional capacity and scale to support its growing customer<br />

base.<br />

Keeping up with an increasing demand<br />

“Our customers’ products support patients around the globe, and<br />

we have supported client projects in over 35 countries to date. We<br />

couldn’t have achieved this without continuously reinventing ourselves,”<br />

says Sam Trimnal, Senior Director of Quality at Alcami.<br />

“When we decided to expand our sterile vial filling capacities to keep<br />

pace with demand, we were looking for a flexible line concept that<br />

would allow us to easily switch between our broad format range of 2<br />

to 50 milliliter vials and could be extended by further format ranges<br />

upon customer requests.”<br />

Expectations were high, since customers demand fill-finish<br />

operations of the highest quality. For Alcami, this not only meant<br />

state-of-the-art equipment, but a solution that would integrate liquid<br />

filling and lyophilization technology in one line. Moreover, the<br />

entire set-up required latest isolator technology for the highest product<br />

and operator safety. Besides producing high-quality injectable<br />

drugs, meeting global regulatory standards such as EU GMP Annex<br />

1 is a key pillar of Alcami’s manufacturing strategy. “We knew this<br />

would pose a considerable challenge to any equipment provider,<br />

since we were looking for an especially high level of flexibility and<br />

regulatory compliance,” Sam Trimnal explains. “But we also knew<br />

there is a company in the market with a great reputation and a unique<br />

approach to designing their lines. We decided to embark on that<br />

demanding journey with them.”<br />

Support like no other<br />

That partner goes by the name of Syntegon, which has specialized in<br />

packaging and processing technology with a proven track record for<br />

comprehensive expertise in both sterile filling and isolator technology.<br />

The strong global presence of more than 30 locations makes it an<br />

exceptionally agile partner. This also showed in the cooperation with<br />

Alcami: “It was only logical to turn to a company that could deliver<br />

in terms of format flexibility and isolator expertise, while providing<br />

on-site support thanks to US-based field service technicians,” Tom<br />

Merola, Director Engineering & Maintenance at Alcami points out.<br />

Alcami opted for a complete sterile vial filling line with isolator<br />

technology from Syntegon. The solution consists of an ARF filling<br />

machine with peristaltic pump filling technology and seven different<br />

formats for maximum flexibility, as well as integrated lyophilization<br />

and VRT capping technology. An HQL sterilization tunnel as well as<br />

upstream and downstream cleaning machines ensure the highest<br />

product safety.<br />

As the line’s centerpiece, the filling and closing platform ARF offers<br />

a versatile solution for industrial production of pharmaceutical<br />

liquids in vials on a smaller footprint. For Alcami, the major benefit<br />

of the ARF is the machine’s format flexibility. The latter allows to<br />

easily switch between seven vial sizes and thus accommodates the<br />

CDMO’s changing fill-finish requirements. Single-use filling components<br />

contribute to the machine’s flexibility. Optional <strong>10</strong>0 percent<br />

in-process control (IPC) adds to safe and reliable results. “Whichever<br />

product or vial size – the ARF enables us to fill different customer<br />

products safely, reliably, and easily. We can react to requests faster<br />

and implement an increased number of customer projects”, Tom<br />

Merola explains.<br />

Safety at all times<br />

Since safe processes are crucial for Alcami, the line comes with proven<br />

isolator technology from Syntegon. The barrier system effectively<br />

separates production areas and personnel, thus contributing<br />

to maintaining the highest hygiene and safety standards. “Our cus-<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 5/28


tomers’ portfolios include products that require utmost protection<br />

– and so do our operators. Thanks to Syntegon’s uniquely designed<br />

isolators, we make sure our staff is always safe,” Sam Trimnal says. To<br />

this effect, Alcami’s new isolator comprises modern air management<br />

and decontamination technology, as well as peripheral systems such<br />

as airlocks, transfer equipment and wireless glove testing.<br />

Before entering the ARF, the containers pass through an RRN<br />

internal cleaning machine for low and medium outputs. Dedicated<br />

stainless steel pipes connect its cleaning stations to the cleaning<br />

media, leading to a hose-free cleaning area with reduced particle<br />

generation. The vials with their particle-free interior are now transferred<br />

to the HQL tunnel, which takes care of sterilization and depyrogenation<br />

via dry heat. Following filling and capping, a RAN external<br />

cleaning machine cleans the vials’ external surface. The design<br />

ensures that the vials’ oversealed caps are protected throughout the<br />

entire process, maintaining the integrity of the delicate products inside<br />

the containers.<br />

Teamwork in Charleston<br />

Despite its complexity and scale, the line was installed smoothly.<br />

“During the Covid-19 pandemic, we had to carry out many project<br />

steps virtually. At the same time, the U.S. field service staff provided<br />

excellent on-site support, when needed. Thanks to Syntegon’s ‘one<br />

face to the customer’ approach and a dedicated project lead, everything<br />

from the initial quote to the final installation worked out the<br />

way we had planned. The good cooperation and coordination between<br />

the teams were our secret to success – Syntegon knows how<br />

to do this and provided the exact solution we needed”, says Tom<br />

Merola.<br />

“Syntegon really lived up to their reputation: they delivered an<br />

excellent turnkey line including both filling and isolator technology<br />

with a small footprint from a single source”, Sam Trimnal adds. So far,<br />

Tom Merola, Director Engineering & Maintenance at Alcami, and Marc<br />

Wilhelms, Business Development Director North America at Syntegon,<br />

are very satisfied with the successful project.<br />

the joint project has proven its worth. Alcami’s new ARF isolator line<br />

is up and running, allowing the company to fill 2 ml vials at an output<br />

of more than 6,000 vials per hour, and more than doubling the daily<br />

production volume in Charleston while complementing four sterile<br />

fill/finish lines in North Carolina. “This is a step change in Charleston<br />

not only for us and our customers, but for patients out there as<br />

well. As much as flexibility matters, so do long-term partnerships,<br />

which we are happy to take to new heights time and again.”<br />

Syntegon Technology GmbH<br />

Blaufelder Straße 45<br />

Telefon: +49 7951 4020<br />

D 74654 Crailsheim<br />

eMail: packaging-ph@syntegon.com<br />

Internet: http://www.syntegon.com<br />

Mit uns wirksam Kosten sparen! WZB - mehr als nur Reinraum<br />

Dekontamination & Sterilisation<br />

Herstellung & Mietservice<br />

www.wzb-reinraum.de<br />

Am Beckerwald 31 · 66583 Spiesen-Elversberg · Telefon +49 6821.7931158<br />

Anzeige Reinraum-Online_quer_178x62 mm ohne Anschnitt<br />

Freitag, 29. Oktober 2021 08:00:44<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Ausgabe DE 05-<strong>2023</strong><br />

Seite 6/<strong>10</strong>3


Gerresheimer expands Technical Competence Center in Wackersdorf with the addition<br />

of new Small Batch Production Sampling Area<br />

Continuing the success story<br />

Gerresheimer, an innovative system and solution provider and global partner for the pharma and biotech industry, is dedicating<br />

even more space to small batch production. It has expanded the capacity of its small-batch production (SBP) area in<br />

Wackersdorf by removing a section of the high-bay warehouse and converting it to a manufacturing space. The new Small<br />

Batch Production Sampling Area Wackersdorf measures 700 square meters and will be used to manufacture pre-series<br />

parts for assembly systems. The expansion is a further display of Gerresheimer’s far-reaching industrialization expertise in<br />

the manufacture of containment solutions, drug delivery systems, and medical devices.<br />

Gerresheimer has taken the next strategic step in its future by expanding<br />

its Technical Competence Center and SBP facilities at the<br />

Wackersdorf location for the third time in just five years. The new<br />

700 square meters Small Batch Production Sampling Area is where<br />

pre-series parts — samples used to set up manufacturing systems —<br />

can be produced at series quality. An area that previously housed a<br />

high-bay warehouse has been converted and equipped to meet the<br />

latest production standards.<br />

Pre-series parts in documented series quality<br />

“This is our response to the changing project environment, which<br />

involves a growing number of large-scale industrialization projects<br />

with many different tools and large machinery,” says Holger Heining,<br />

Head of Small Batch Production Gerresheimer Regensburg GmbH,<br />

Wackersdorf. “For their high-volume assembly systems, industrialization<br />

projects require a large quantity of pre-series parts in documented<br />

series quality at an early stage of the project cycle. With our<br />

new Small Batch Production Sampling Area, we can now meet these<br />

demands and handle the rising number of large-scale industrialization<br />

projects in the best possible manner.”<br />

Automatic tool handling<br />

Unlike development projects, industrialization projects require automatic<br />

tool handling for high-volume manufacturing. The new area<br />

reflects these new parameters, featuring <strong>10</strong> injection molding machines<br />

with a clamping force of 175 to 420 metric tons.<br />

A decade of small-batch production<br />

Small-batch production at Wackersdorf in the Upper Palatinate region<br />

of Germany started up exactly ten years ago. In 2013, the first<br />

injection molding machine and automation solutions at the location<br />

were installed in a small room. The setup proved to be resounding<br />

success, kicking off a series of expansions to the facility. The first<br />

parts of the warehouse were converted to clean room production<br />

areas for injection molding and the assembly of plastic products in<br />

2015. Three years later, in 2018, Gerresheimer invested an eight-digit<br />

figure in the construction of new grade C and grade D clean rooms<br />

and expanding its small-batch expertise to the glass sector.<br />

In 2020 and 2021, the company made another eight-digit investment<br />

at the Wackersdorf location, this time focusing on plastics.<br />

By expanding the production area to 2,750 square meters in<br />

total, Gerresheimer responded to the growing number of projects<br />

that require smaller batches or a small quantity of pre-series products<br />

for development, approval, and industrialization purposes.<br />

The investment involved the construction of new office space but<br />

predominantly focused on creating ISO class 7 and 8 clean room<br />

facilities.<br />

Wackersdorf now has 2,170 square meters of class 7 and 8 clean<br />

room production space, a 220 square-meter controlled area, and a<br />

360 square-meter clean room for pharmaceutical glass products that<br />

meets GMP class C and D requirements.<br />

Qualified staff wanted – over 40 new jobs created<br />

in Wackersdorf<br />

Gerresheimer is continuing on its growth trajectory, and the Wackersdorf<br />

location is no exception. That’s why the highly motivated,<br />

dynamic team is looking for new faces in the shape of experienced<br />

experts, young talents, and trainees who are keen to use state-ofthe-art<br />

approaches, systems, and methods to contribute to the success<br />

of the projects and of the company as a whole. Gerresheimer<br />

intends to create over 40 new jobs in Wackersdorf over the coming<br />

months.<br />

With a team of around 520 in Wackersdorf and a further 650<br />

employees just 30 km away in Pfreimd, Gerresheimer is one of the<br />

larger employers in the region. Overall, the MDAX-listed company<br />

employs around 11,000 people worldwide.<br />

The new Small Batch Production Sampling Area at the Gerresheimer<br />

Technical Competence Center in Wackersdorf<br />

Gerresheimer AG<br />

D 40468 Düsseldorf<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 7/28


Cyto-Facto Inc.:<br />

Advancing cell &<br />

gene therapies,<br />

providing the<br />

promise of health<br />

Cyto-Facto Inc. Cell and Gene Therapy Facility hallway<br />

In April <strong>2023</strong>, Cyto-Facto Inc. (CF), a spin-off of the Foundation for<br />

Biomedical Research and Innovation at Kobe, Japan, began manufacturing<br />

gene and cell preparations to meet a worldwide growing<br />

need for new treatments that leverage a patient’s immune system to<br />

fight disease. One example is an emergent gene therapy like CAR-<br />

T (Chimeric Antigen Receptor T-cell/CAR-T cell), which is showing<br />

enormous promise in the treatment of lymphatic cancers. However,<br />

robust process needs, including controlled, sterile environments,<br />

make the manufacture of cell and gene therapies complex and costly.<br />

With a solid track record in R&D and manufacturing investigational<br />

and commercial products, Cyto-Facto Inc. has long experience<br />

in compliance with GMP (Good Manufacturing Practice), and<br />

process development for gene and cell preparations. A large team of<br />

accomplished personnel has allowed Cyto-Facto Inc. to begin developing<br />

and producing life-saving drugs and treatments.<br />

Cyto-Facto Inc. CEO and President Shin Kawamata has faith in<br />

the competency of the company’s staff. „Because the raw materials<br />

for cellular medicine are living organisms, sterility and standardization<br />

are difficult to achieve, as is proper implementation of the<br />

manufacturing process,” said Kawamata. “The need to maintain a<br />

heavy-duty HVAC system and high costs are hurdles to commercialization<br />

and industrialization. In addition, the initial stage requires<br />

manual manufacturing methods, which must be performed by skilled<br />

personnel.”<br />

Compliance with Good Practices for GCTP<br />

While conventional drug and medical device reviews focus on the<br />

technical aspects of manufacturing and quality control, the regulations<br />

regarding GCTP (Good Gene, Cellular, and Tissue-based Products<br />

Manufacturing Practice - Source PMDA) require more specialized<br />

knowledge of the biological properties of cells and tissues and<br />

their therapeutic effects. Because GCTP products are individualized<br />

therapies that utilize the cells and tissues of an organism, unlike conventional<br />

small molecule-based drugs, clinical trials and reviews are<br />

conducted on an individual basis, with stricter rules for the production<br />

and management of products to ensure safety and efficacy.<br />

CF implemented the Vaisala viewLinc continuous monitoring<br />

system in their controlled environments to ensure compliance with<br />

strict GCTP regulations. Since CF provides Cell Processing Centers<br />

(CPCs) for clinical trials and commercial development, the company<br />

needs to meet the requirements of each client, including the layout<br />

of the equipment in the processing center and the items to be monitored.<br />

The Vaisala viewLinc monitoring system can be configured with<br />

wireless data loggers to flexibly accommodate layout changes. In addition,<br />

the ability to use virtual servers and the ease-of-use of the<br />

software interface are ideal for managing the complex CPCs. As a<br />

sensor manufacturer, Vaisala also offers a wide array of measured<br />

parameters, device connectivity options, and support services. With<br />

audit trail and user administration features, the viewLinc software<br />

is compliant with GxP and global regulations. Vaisala also supports<br />

compliance with its GxP documentation package and comprehensive<br />

IQOQ protocols.<br />

Before the viewLinc monitoring system was installed, Cyto-<br />

Facto Inc. conducted a preliminary radio signal test to verify that<br />

viewLinc’s RFL<strong>10</strong>0 data loggers’ wireless communication was fully<br />

functional across CPCs in separate buildings. This initial demonstration<br />

allowed for the AP<strong>10</strong> network access points and wireless data<br />

loggers to be properly positioned and the system was implemented<br />

quickly.<br />

Environmental Monitoring before viewLinc<br />

Prior to the introduction of the Vaisala continuous monitoring system,<br />

sensors without data logging capabilities sent environmental<br />

data to a centralized monitoring system. However, this entailed the<br />

risk of data loss in the event of a communication failure. In addition,<br />

the old system required an on-premise server, supported by periodic<br />

data backups and maintenance, which placed an extra burden<br />

on staff. The monitoring system software only provided one level<br />

of access privileges. Access privileges were granted only to specific<br />

personnel who had received training, to limit the number of operators<br />

and avoid errors and data modification. With Vaisala’s viewLinc<br />

monitoring system, detailed user access permissions can be configured<br />

at multiple levels to achieve highly secure operations with flexible<br />

and lean staffing. Easy administration of user access rights also<br />

supports GxP compliance.<br />

Advantages of Vaisala Wireless Loggers:<br />

No Communication Failures<br />

Today Cyto-Facto has over one hundred Vaisala RF<strong>10</strong>0 wireless<br />

data loggers operational in its manufacturing and cell storage environments.<br />

Because cell processing centers have small, controlled<br />

environments, such as refrigerators, freezers, and CO2 incubators,<br />

there were initial concerns about using wireless connectivity for<br />

data loggers. However, the Vaisala VaiNet wireless technology uses a<br />

uniquely powerful wireless platform based on LoRa modulation, and<br />

the VaiNet data loggers have proved to be reliable.<br />

Environmental data in controlled environments has implications<br />

for manufacturing parameters and process control in the development<br />

of gene and cellular preparations, so seamless data collection is<br />

extremely helpful for ensuring quality. viewLinc is also used to cen-<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 8/28


Multi-parameter RFL<strong>10</strong>0 data logger with probe splitter<br />

Mounted RFL<strong>10</strong>0 monitoring data logger<br />

tralize data from different areas, such as quality control and storage<br />

facilities. The viewLinc View settings allow users to centrally display<br />

the rooms through which the material passes and then trace the<br />

temperature and humidity at the time of passage, as well as display<br />

the conditions of the equipment and CPC at the time of production.<br />

Cell standardization supported by QbD<br />

Currently, Cyto-Facto Inc. is particularly focused on cell standardization.<br />

The purpose is to clearly define rules and standards and to<br />

ensure a stable supply of cells with guaranteed safety. Efforts to standardize<br />

and automate the cell therapy field to develop new products<br />

and efficient production models are a major milestone toward commercial<br />

manufacturing. However, cell therapy manufacturing is difficult<br />

to standardize and automate. One solution may be using a Quality<br />

by Design (QbD) approach for in-process monitoring to ensure<br />

mechanisms and procedures that ensure optimal quality are designed<br />

into all processes. Another solution is advancing technologies.<br />

„Cloud-based software is being developed to set up a good variation<br />

of standards and automate them with in-process monitoring,<br />

which will ensure quality and reduce costs. Digitalization will be the<br />

trend of the future,” said Kawamata. „In the cell culture process, there<br />

are many factors that affect the condition and quality of the cells.<br />

For example, the type and concentration of the medium, temperature,<br />

CO2 concentration, and cell density.<br />

“QbD allows us to evaluate how these factors impact quality<br />

and to find the ideal conditions, which also helps automate the cell<br />

culture process. Real-time monitoring of high-precision measured<br />

data and constant maintenance of optimal in-process environmental<br />

conditions have great potential to contribute to the realization of<br />

automation and mass production in the future.”<br />

„Instead of using destructive testing for the final test, I would like<br />

to build on the QbD concept, pioneering the use of technological innovations<br />

to create in-process monitoring that can be automated<br />

and the use of a system that collects data in the cloud.”<br />

Shin Kawamata, CEO & President of Cyto-Facto Inc.<br />

Cyto-Facto Inc. is currently working with several companies to develop<br />

new, optimized systems. One example is the Application Messaging<br />

Platform (AMP), a new GxP-compliant cloud service that fully<br />

digitizes the cell manufacturing process, ensuring both quality and<br />

cost benefits. AMP digitizes operations throughout the facility, from<br />

the delivery of patient cells and raw materials to planning, cell processing,<br />

analysis, review, and shipping. With real-time monitoring<br />

and review, product safety and efficacy are ensured through the digitization<br />

of all records of cell processing.<br />

It also allows for integrated collection and monitoring of values<br />

such as pH, glucose, lactate, and pH vs. glucose to model complex<br />

cell manufacturing processes visually, easily, and flexibly. AMP is<br />

also expected to be a major step forward in automation, as it can adjust<br />

the overall manufacturing schedule and prevent missing or outof-date<br />

raw materials through RFID (radio frequency identification).<br />

Ecosystems that coexist with people, medicine, and society<br />

From the viewpoint that the formation of new industries will lead<br />

to the sustainable development of the Kobe Biomedical Innovation<br />

Cluster, Cyto-Facto Inc. is leading the way not only within the scope<br />

of cutting-edge medical care, but also as a role model in the community.<br />

A core facility in the Biomedical Innovation Cluster, Cyto-Facto<br />

is part of an experiment in building a comprehensive ecosystem that<br />

includes education and community outreach.<br />

„Through educational outreach activities at local schools and<br />

participatory experiences such as projection mapping, we are providing<br />

places where children can develop an interest in cells and learn<br />

about cancer cells and CAR-T cells,” said Kawamata. “In this way, we<br />

hope to deepen the local community‘s understanding of disease and<br />

to create a system to live in harmony with the community. So, we are<br />

working on creating and producing scripts for events and YouTube<br />

distribution.”<br />

The viewLinc monitoring system monitors temperature, humidity,<br />

differential pressure, particulate and carbon dioxide in various<br />

applications at Cyto-Facto, including safety cabinets, clean rooms,<br />

storage facilities, incubators and more. In addition, the company<br />

uses Vaisala sensors and transmitters to measure and monitor material<br />

gas supply and residual pressure. Vaisala measurement technologies<br />

and systems will continue to be a part of Cyto-Facto’s complex<br />

cell and gene therapy operations, supporting advanced medicine<br />

that use living cells that provide hope for new, life-saving drugs and<br />

therapies.<br />

Application Messaging Platform (AMP)<br />

Vaisala GmbH<br />

Rheinwerkallee 2<br />

D 53227 Bonn<br />

Phone: +49 228 2497<strong>10</strong><br />

Fax: +49 228 2497111<br />

email: vertrieb@vaisala.com<br />

Internet: http://www.vaisala.de<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 9/28


New plant in Germany is 40%<br />

more energy efficient with<br />

Siemens technology and services<br />

– Pfizer’s new high containment production plant is one of the world’s<br />

most modern and sustainable; uses 40% less energy for environmental<br />

control than traditional facilities<br />

– Special containment concept, monitored and controlled by Building<br />

Services from the Siemens Xcelerator portfolio, boosts safety for<br />

employees handling high-potency ingredients<br />

– Siemens technology integrates building and production data via Desigo CC<br />

Pharmaceutical company Pfizer has opened<br />

a new high-containment manufacturing facility<br />

in Freiburg, Germany, using technology<br />

and services from Siemens to make it one of<br />

the most modern and sustainable of its kind.<br />

Potentially producing up to seven billion tablets<br />

a year for more than 180 countries, the<br />

plant uses an innovative containment concept<br />

- monitored and controlled by Building<br />

Services from Siemens Xcelerator portfolio<br />

- which ensures employee safety and results<br />

in a 40 percent reduction in energy use in its<br />

environmental control system, compared to<br />

a traditional facility.<br />

Building management platform Desigo<br />

CC is the technology backbone of the facility’s<br />

smart building infrastructure, acting as<br />

a central control center to integrate multiple<br />

systems and devices, and automate processes.<br />

This enables systems to communicate<br />

Die neue High-Containment-Produktionsstätte von Pfizer in Freiburg.<br />

and collaborate with each other, collecting<br />

and visualizing data from both the production<br />

process and the building in one place.<br />

“All machines and processes are intelligently<br />

networked using information and<br />

communication technologies, which enables<br />

the Pfizer plant in Freiburg to produce<br />

more flexibly, faster and with less resource<br />

consumption,” said Gunther Bechmann,<br />

Senior Manager Operations Manufacturing,<br />

Pfizer Freiburg. “The constructive cooperation<br />

on this project has once again confirmed<br />

and expanded the existing partnership<br />

that the Pfizer plant has maintained with<br />

Siemens for years.”<br />

High containment plants are designed<br />

to safely manufacture medications with<br />

highly active ingredients, which require<br />

handling with the greatest of care. At the<br />

Pfizer plant, Building Services from Sie-<br />

mens monitor and control a special containment<br />

concept, bringing together multiple<br />

disciplines including power distribution,<br />

ventilation, air conditioning and heating. As<br />

a result of this concept and its technology,<br />

Pfizer can manufacture medications with<br />

category Occupational Exposure Bands<br />

Four (OEB4), with employees only requiring<br />

protective clothing to OEB3 level. This creates<br />

optimum production conditions, while<br />

ensuring maximum safety for employees<br />

and increasing efficiency.<br />

“Our work with Pfizer on the new Freiburg<br />

plant is an excellent demonstration of<br />

how applying an intelligent mix of technology<br />

and services can produce exactly the<br />

right outcomes, even in a challenging industry<br />

like pharmaceuticals, where speed, consistent<br />

quality and safety are all non-negotiable,”<br />

said Dave Hopping, CEO, Solutions<br />

and Services, Siemens Smart Infrastructure.<br />

“The result is a faster, more flexible and<br />

competitive facility, and a benchmark in<br />

ultra-modern, sustainable pharmaceutical<br />

production.”<br />

Combining Desigo CC with SIMATIC<br />

WinCC - a scalable process visualization<br />

system - enables production-related data<br />

to be exchanged between the production<br />

systems and the visualization system. Data<br />

relevant to production from the building<br />

management platform is transferred to the<br />

supervisory control and data acquisition<br />

(SCADA) system, while information from<br />

other production systems can be fed into<br />

Desigo CC and used for predictive control<br />

functions in the building automation systems.<br />

This connection allows building management<br />

data to be used in the central management<br />

system, and can be accessed at<br />

any time from individual production areas.<br />

Networking and visualizing data in this way<br />

enables the production facility to consume<br />

around 40 percent less energy than traditional<br />

plants in its environmental control,<br />

by intelligently controlling the air flow and<br />

temperature requirements in individual zones.<br />

Forming part of Siemens Xcelerator,<br />

Building Services is a portfolio of onsite and<br />

remote services which improve the operation<br />

and maintenance of buildings, through<br />

data-driven, outcome-based service programs.<br />

Siemens Xcelerator is an open digital<br />

business platform to accelerate digital transformation,<br />

comprising a curated portfolio,<br />

a partner ecosystem and a marketplace to<br />

speed up value creation across industry,<br />

buildings, grids and mobility.<br />

Siemens AG<br />

D 80333 München<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page <strong>10</strong>/28


Receiving MHRA approval<br />

– UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy<br />

– Highly experienced team ready to support ATMP innovators at all stages<br />

– Offering comprehensive range of services from early process and analytical development<br />

through cGMP manufacturing for clinical trials<br />

Rentschler Biopharma SE, a leading global contract development<br />

and manufacturing organization (CDMO) for biopharmaceuticals,<br />

including advanced therapy medicinal products (ATMPs), today announced<br />

that it has received the cGMP Manufacturing Compliance<br />

Certificate, following the successful inspection by the UK Medicines<br />

& Healthcare Products Regulatory Agency (MHRA) at its UK site.<br />

The ATMP business was announced in early 2021 and the facility is<br />

located in the Cell and Gene Therapy Catapult’s Manufacturing Innovation<br />

Centre in Stevenage.<br />

Dr. Robert Panting, General Manager of Rentschler’s ATMP<br />

business, said: “MHRA’s approval marks a major milestone for Rentschler<br />

Biopharma, and we are excited to offer our services from process<br />

and analytical development through cGMP manufacturing. Our<br />

team is highly knowledgeable, bringing years of experience in the<br />

field of AAV. We provide a tailored program for each client, in line<br />

with their needs and stage of development, while working closely<br />

with them to move projects forward as rapidly as possible. We are<br />

thus continuing the Rentschler tradition of offering a truly clientcentric<br />

approach with the ultimate goal of helping patients. With our<br />

first clients already on board, we look forward to adding other exciting<br />

programs soon.”<br />

Dr. Christian Schetter, Chief Scientific Officer of Rentschler<br />

Biopharma, commented: “Our contribution to improving the health<br />

and quality of life of seriously ill patients, is made possible by continuously<br />

expanding our expertise in the production of essential biopharmaceuticals.<br />

By launching Rentschler’s ATMP business, we aim<br />

to address an important gap in expertise and support for innovative,<br />

early-stage cell and gene therapy programs. It is gratifying to achieve<br />

this important milestone of MHRA approval, bringing us closer to<br />

reaching our objective of supporting clients already from the earliest<br />

stages of CMC development. We are continually looking to understand<br />

not only current client needs but future ones as well, which is<br />

how our ATMP offering came to fruition. We will continue to listen<br />

to our clients to anticipate how we can improve our offering and collaborate<br />

in advancing medicine to save lives, together.”<br />

Following the successful MHRA inspection, Rentschler Biopharma’s<br />

ATMP business can now offer its full range of services for the<br />

clinical supply of AAV, including bioprocess and analytical development<br />

through to cGMP manufacturing at their Stevenage facility in<br />

the UK. The company works to be a true partner to entrepreneurial<br />

players to enable them to transform their ideas into real products<br />

with the potential to treat and even cure patients with serious and<br />

life-threatening diseases.<br />

Rentschler Biopharma SE<br />

D 88471 Laupheim<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 11/28


Winning two of this year’s<br />

German Packaging Awards<br />

This September, SÜDPACK is the proud recipient of two of the renowned German Packaging Awards. The film manufacturer<br />

impressed the German Packaging Award’s jury of leading experts with a recyclable bag for cheese ripening in the “new<br />

material” category and with a recyclable film concept for blister packaging for solid applications in the “sustainability/<br />

recyclability” category. What the two solutions have in common is that they are both based<br />

on recyclable mono-materials and stand out due to their greater material efficiency<br />

and reduced carbon footprints. On September 13, the SÜDPACK and<br />

SÜDPACK Medica teams accepted the two awards during the traditional<br />

cer-emony in Berlin.<br />

The two awards, which now join the<br />

many that were proudly accepted before<br />

them, add to SÜDPACK’s story of success. At the<br />

same time, the manufacturer of high-performance films<br />

has impressively underscored its role as a leader in technology<br />

and innovation in the market. Valeska Haux, Vice President of Strategic<br />

Marketing, is particularly pleased about that fact that “we were<br />

able to also win over the expert jury with a recyclable blister concept<br />

for the pharma-ceutical industry. After all, SÜDPACK is not just a<br />

leader in sustainability with its pioneering packaging concepts in<br />

the food industry, but also in the medical goods and pharmaceutical<br />

industries.”<br />

With the Tubular Bag PurePE …<br />

SÜDPACK is setting standards in recyclability, material efficiency<br />

and in the re-duction of carbon footprints. The polyethylene-based<br />

concept, which has been certified with a recyclability of 96% by the<br />

renowned Institute cyclos-HTP, is already established on the market.<br />

Compared to conventional film structures, this innovative packaging<br />

solution reduces resource consumption by 23% by using a<br />

thinner film measuring 30 µm in thickness – all while maintaining<br />

the same functionality as well as maximum process and packaging<br />

reliability. What SÜDPACK has achieved is “nothing short of a packaging<br />

revolution” in the cheese ripening industry by reducing the<br />

car-bon footprint by -52 g CO2/m², or 19%. “These results could indeed<br />

be of par-ticular interest to milk processors who operate internationally<br />

and who are focusing more and more on sustainable<br />

packaging concepts,” emphasized Valeska Haux. At the moment, the<br />

film manufacturer is seeing an increasing demand for PE-based film<br />

concepts, because these mono-structures are classi-fied as recyclable<br />

in many countries.<br />

“With our Tubular Bag PurePE, we have an ideal substitute for<br />

conventional PA/PE structures because it maintains the same high<br />

requirements for product protection and functionality. This covers<br />

the individual barrier properties that are essential for cheese ripening,<br />

the maturation process and puncture re-sistance.” Last but not<br />

least, close cooperation with machine manufacturers ensures that<br />

the packaging concept can be optimally processed on full and semiautomatic<br />

packaging machines.<br />

PharmaGuard – for added sustainability<br />

when packaging solid applications<br />

SÜDPACK Medica’s PP-based and recyclable film concept for blister<br />

packaging has also already been launched on the market. The<br />

base and lidding films pro-duced in an innovative coextrusion process<br />

feature a groundbreaking array of characteristics, including<br />

high transparency and barrier functionality. “What is worth particular<br />

mention is the excellent water vapor barrier thanks to having PP<br />

as the base material,” added Valeska Haux. The perfectly matched<br />

films guarantee top sealing performance, which is reflected by maximum<br />

process reliability and packaging quality.<br />

A life cycle assessment conducted by Sphera has proven that<br />

the packaging concept is associated with a greatly reduced climate<br />

impact (in CO2-eq) of up to 47% as well as lower energy and water<br />

consumption compared to other com-monly used PVC/PVdC and<br />

aluminum blister solutions.<br />

Recognition<br />

With the 46th German Packaging Award ceremony, a total of 34 innovations<br />

from Germany, England, the Netherlands and Austria were<br />

distinguished this year. What particularly delighted the independent<br />

jury was the “high quality, diversity and range of the submissions as<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 12/28


well as the clear focus in the areas of sustainability, circular economy<br />

and climate and environmental protection.”<br />

The winners received their awards on September 13 in Berlin’s<br />

Meistersaal located at Potsdamer Platz. For SÜDPACK and<br />

SÜPACK Medica, teams came from the Application Technology,<br />

Business Development, Sales and Sustainabil-ity departments.<br />

PharmaGuard impressed the jury “with its use of PP as a suc-cessful<br />

alternative to conventional, non-recyclable blister packaging,<br />

making it a recyclable packaging solution. The very good shaping<br />

of the cavities of the blis-ter and the balanced PP-based covering<br />

film, which showed a clear functionali-ty, are particularly noteworthy<br />

in this development.”<br />

The jury’s statement for the Tubular Bag PurePE concept concluded<br />

that it “succeeded in converting an existing PA/PE packaging<br />

into a mono-solution through successfully selecting and combining<br />

innovative granulates, whilst at the same time ensuring the<br />

functional barrier for cheese ripening as well as puncture resistance<br />

required for this product. On top of this, the material reduction<br />

of 23% compared to conventional cheese maturing bags was<br />

impressive.”<br />

SÜDPACK Verpackungen GmbH & Co. KG<br />

D 88416 Ochsenhausen<br />

Identified as best-in-class CDMO in global biopharmaceutical<br />

aseptic fill-and-finish services<br />

Earning Frost & Sullivan’s Customer<br />

Value Award for the third time<br />

We have been awarded the Frost &<br />

Sullivan’s <strong>2023</strong> Global Customer Value<br />

Leadership Award in the aseptic filland-finish<br />

market for the high performance<br />

for our customers. The award,<br />

presented annually by the international<br />

growth strategy consulting firm,<br />

focuses on both business and customer<br />

impact along with industry status<br />

and trends in the market. In previous<br />

years we were awarded for our Customer<br />

Value Leadership and for our Customer<br />

Service Leadership.<br />

Best practices in operational<br />

efficiency and customer processes<br />

Frost & Sullivan recognizes the companies that offer products or<br />

services customers find superior for the overall price, performance,<br />

and quality. The firm applies a rigorous analytical process to evaluate<br />

multiple nominees for each award category before determining<br />

the final recipient. The process involves a detailed evaluation of best<br />

practices criteria across the two dimensions – business and customer<br />

– for each nominated company.<br />

Vetter’s core service offerings include drug product development,<br />

clinical and commercial aseptic filling, device assembly and<br />

secondary packaging. The award details our consistent and successful<br />

efforts to put the customer at the center of our operations.<br />

Unmatched customer service experience<br />

In response to the announcement, Frost & Sullivan’s Senior Industry<br />

Analyst Surbhi Gupta said, “Vetter<br />

offers highly specialized, state-of-theart<br />

parenteral development and manufacturing<br />

expertise for the entire<br />

life cycle, from clinical development<br />

to commercial production and packaging.<br />

Through unwavering dedication<br />

to delivering the highest quality products<br />

and services and their exceptional<br />

knowledge and expertise, they<br />

strive to ensure their customers receive<br />

the best possible services.”<br />

Recognition of strong<br />

financial performance<br />

Additionally, Frost & Sullivan’s Best Practices Research Analyst<br />

Pavel Zhebrouski remarked, “In 2021, we recognized Vetter for its<br />

business and customer impact, and we remain impressed with the<br />

continuous innovation and sustained leadership. Vetter uniquely leverages<br />

its expertise to meet its customers’ needs, particularly the<br />

growing transition to injectables.”<br />

Vetter Managing Director Peter Soelkner is proud of the industry<br />

recognition: “We always make our best efforts to provide customers<br />

with qualities that are highlighted in this prestigious award. We leverage<br />

our seven decades of experience and over 6,000 employees<br />

to do so.”<br />

Managing Director fellow Thomas Otto emphasizes: “We graciously<br />

acknowledge that this award shows we are on the right path,<br />

and we are looking to continue this approach towards the future.”<br />

Vetter Pharma International GmbH<br />

D 88212 Ravensburg<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 13/28


Thanks to their standardized and modular design, the Pharmatec SVP<br />

process systems can be adapted to a wide range of production needs.<br />

Syntegon at CPHI Barcelona:<br />

New solutions for small and<br />

micro batches<br />

– Market launch: gloveless, Annex 1-compliant production cell Versynta microBatch<br />

– Synexio: cloud-based software solution offers seamless data transparency<br />

– Xelum feeder-blender module and TPR 200 Plus: the new way of continuous direct compression<br />

At CPHI Barcelona <strong>2023</strong>, Syntegon will showcase new developments<br />

for the filling and processing of small and micro batches. Equipment<br />

designed specifically for small batch sizes is in high demand not only<br />

for research and development, but also for the commercial production<br />

of liquid and solid pharmaceuticals. Visitors to booth 3S50 will<br />

see two innovations from Syntegon: Versynta microBatchand the<br />

TPR 200 Plus. In addition, the cloud-based software solution Synexio<br />

will be connected to Versynta microBatch.<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 14/28


The cloud-based software solution Synexio from Syntegon<br />

enables the collection, evaluation, and visualization of machine<br />

and production data.<br />

and maintenance management at fixed prices. „For new machines,<br />

we initially recommend level 4 from the seven available levels,“ Hein<br />

explains. This includes all preventive maintenance work as well as<br />

training.<br />

The fully automated production cell Versynta<br />

microBatch from Syntegon fills between 120 and<br />

500 containers per hour with virtually no product loss.<br />

Market launch: Versynta microBatch live on show<br />

Following the first digital presentation of the new Versynta micro-<br />

Batch at Achema 2022, the official market launch will follow at CPHI<br />

Barcelona: “Pharmaceutical and biotech companies require increasingly<br />

flexible equipment for new, highly effective drugs, including<br />

new developments in cell and gene therapy, for ever smaller patient<br />

groups,” says Klaus Ullherr, Senior Product Manager at Syntegon.<br />

“Maximum product yield and fast changeovers are paramount, especially<br />

for very small batches. We will demonstrate how the Versynta<br />

microBatch meets these requirements live at our booth.”<br />

The fully automated production cell, which already won the German<br />

Packaging Award in 2022, fills between 120 and 500 syringes,<br />

cartridges, and vials made of glass or plastic per hour with virtually<br />

no product loss and with <strong>10</strong>0 percent in-process control. Five integrated<br />

inline inspection systems ensure continuous process monitoring<br />

and provide particular safety by inspecting tubs, stoppers, and<br />

caps. Requirements of the new Annex 1 were also taken into account<br />

during development. For example, the gloveless isolator with integrated<br />

air management significantly reduces the risk of contamination.<br />

Optional network cameras facilitate continuous remote production<br />

monitoring in the isolator.<br />

Synexio: demonstration and sneak preview<br />

The cloud-based software solution Synexio is also on show at CPHI.<br />

It enables the collection, evaluation, and visualization of machine<br />

and production data. „In addition to the visualization of KPIs and<br />

machine availability and the identification of concrete improvement<br />

potential, visitors will get a first glimpse of the third Synexio package<br />

called ‚Empower‘. It includes component monitoring, which we will<br />

demonstrate using specific use cases,“ says Elisa Hein, Product Manager<br />

Expert Services at Syntegon. Synexio is part of Syntegon‘s<br />

Service Agreements, which form the basis for effective equipment<br />

The new way of continuous direct compression<br />

The trend towards small batches also accounts for the production<br />

of solid oral dosage forms. The Xelum platform offers continuous<br />

solutions, from fluid bed granulation to direct compression. In both<br />

cases, the same feeder-blender module can be used. In the configuration<br />

shown at the booth, the module doses and mixes individual<br />

packages, so-called X-keys. They ensure easy traceability and precise<br />

dosing, even and especially for active ingredients of less than 1%.<br />

Losses caused by starting and stopping are eliminated. The packages<br />

are continuously fed into the TPR 200 Plus tablet press, which enables<br />

efficient and user-friendly downstream processing. It features<br />

a light containment concept with dust-tight machine protection up<br />

to OEB 3. With the APD feeder, including automatically adjustable<br />

powder infeed in the filling shoe and the APD software, manufacturers<br />

can determine the optimum parameters for the formulation<br />

feed into the die.<br />

SVP process systems: maximum flexibility<br />

Versatility is a key characteristic of Syntegon’s portfolio for liquid<br />

pharmaceuticals. This includes the Pharmatec SVP process systems<br />

for the formulation of small-volume liquid pharmaceuticals in batch<br />

sizes from 13 to 3,000 liters, which will be displayed as 3D model<br />

at CPHI Barcelona. Thanks to their standardized modular design,<br />

the process systems can be adapted to a wide range of production<br />

needs. With the latest addition to its portfolio – the highly modular,<br />

fully automated SVP Essential – Syntegon offers pharmaceutical<br />

manufacturers a cost-effective alternative with maximum flexibility<br />

and short delivery times.<br />

Syntegon Technology GmbH<br />

Blaufelder Straße 45<br />

D 74654 Crailsheim<br />

Telefon: +49 7951 4020<br />

eMail: packaging-ph@syntegon.com<br />

Internet: http://www.syntegon.com<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 15/28


Numerous innovations and further developments will also be presented in the deburring tools<br />

area, for example the world’s first chamfering cutter with a V-shaped cutting edge that fully<br />

excludes the occurrence of any secondary burrs. (Image source: Kempf)<br />

5th Leading Trade Fair for Deburring Technology and Precision Surface<br />

Finishing <strong>10</strong> to 12 October <strong>2023</strong> at the Karlsruhe Exhibition Centre in Germany<br />

DeburringEXPO – New Solutions<br />

and Know-How for Efficient<br />

and Sustainable Deburring and<br />

Surface Finishing<br />

The deburring and surface finishing sector will meet again at DeburringEXPO at the Karlsruhe Exhibition Centre from the<br />

<strong>10</strong>th through the 12th of October, <strong>2023</strong>. Market and technology leaders, hidden champions, start-ups and research institutes<br />

will present innovative and further developed solutions and services for current and future challenges in these quality<br />

and cost-relevant manufacturing steps. The internationally unique spectrum of exhibitor offerings is rounded out with an<br />

attractive supplementary programme including theme parks and a bilingual expert forum.<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 16/28


The exhibitors will not only present various innovative solutions for<br />

automated deburring – a special show area will also be dedicated<br />

to this topic. (Image source: Botzian & Kirch GmbH)<br />

The focal points of the three-day, integrated expert forum with a total<br />

of 23 simultaneously interpreted presentations (German English)<br />

include fundamentals, approaches to process and cost optimisation and<br />

reports on best practice applications and current trends, as well as on<br />

content provided by the theme parks. (Image source: fairXperts)<br />

Manufacturing companies are currently facing major challenges that<br />

will have to be mastered in order to remain competitive. A somewhat<br />

lower priority is often assigned to production steps such as deburring,<br />

edge rounding, component cleaning and surface finishing – unjustifiably<br />

so, because enormous potential is available for optimisation in<br />

these production processes. As the only international information<br />

and procurement platform for these disciplines, DeburringEXPO<br />

identifies opportunities targeted at improvement, streamlining and<br />

enhanced resource efficiency in the relevant processes for investment<br />

decision-makers, developers, design engineers and technical<br />

purchasing agents, as well as manufacturing and production managers.<br />

“This is reflected on the one hand by the numerous innovations<br />

and further developments presented by the exhibitors at the leading<br />

trade fair for deburring technologies and precision surface finishing.<br />

Furthermore, solutions are also provided for dealing with the current<br />

shortage of skilled personnel,” reports Hartmut Herdin, managing<br />

director of private trade fair promoters fairXperts GmbH & Co. KG.<br />

“On the other hand, the supplementary programme with its various<br />

theme parks and the expert forum is also geared towards offering<br />

companies inspiration and suggestions for optimising processes, reducing<br />

costs and increasing sustainability.”<br />

Innovations and Further Developments for All Applications<br />

Whether market and technology leaders, hidden champions, startups<br />

or research institutes are involved – exhibitors traditionally take<br />

advantage of DeburringEXPO to premiere innovations and further<br />

developments to its expert audience. These include world’s firsts<br />

such as a self-learning deburring robots for toothed parts and the<br />

first chamfering cutter with a V-shaped cutting edge, which prevents<br />

secondary burrs and thus the need for additional, downstream deburring<br />

processes. New systems and methods for fully automated<br />

deburring and cleaning of components in a single process – using<br />

high-pressure water jet techniques as well as ultrasound or dry processes<br />

with CO2 granulate – will also be presented. New and further<br />

developed products, technologies, processes and services in the<br />

field of micromachining, as well as for energy and resource-efficient<br />

production of application-oriented surfaces, is also facilitating optimisation<br />

targeted at boosting competitiveness.<br />

Theme Parks Covering Aspects with Relevance for Competition<br />

The three theme parks at this year’s DeburringEXPO also provide<br />

inspiration for mastering current and future challenges. For example,<br />

the theme park for “Quality Assurance in the Deburring Process”<br />

provides targeted information on various measuring methods, as<br />

well as their strengths and limitations, in order to verify compliance<br />

with ever stricter specifications in the areas of deburring, edge rounding<br />

and surface finishing. The special show on “Automated Deburring”<br />

presents the most up-to-date options for automated polishing,<br />

grinding and deburring of components with robots, which also<br />

plays a role in confronting the current shortage of skilled personnel.<br />

Whether before or after deburring, technical cleanliness in accordance<br />

with the specified requirements is an essential prerequisite<br />

for the quality of downstream processes, and thus for high-quality<br />

components as well. Corresponding methods and processes will be<br />

presented in the “Cleaning After Deburring” theme park.<br />

Bilingual Expert Forum – Knowledge, Trends and Best Practice<br />

Applications<br />

“As a supplement to the exhibitors’ cross-technology, multi-material<br />

and inter-industry spectrum of solutions, DeburringEXPO ensures<br />

an effective transfer of knowledge at the integrated, three-day expert<br />

forum,” explains Hartmut Herdin. The programme, featuring<br />

a total of 23 simultaneously interpreted presentations (German <br />

English) by experts from industry and science, is divided into five<br />

thematic blocks: “mechanical deburring”, “quality assurance”, “automated<br />

deburring with industrial robots”, “cleaning after deburring”<br />

and “non-mechanical deburring”. Presentation focal points include<br />

fundamentals, approaches to process and cost optimisation, reports<br />

on best practice applications and current trends. Trade fair visitors<br />

are admitted free of charge and will also receive a free copy of the<br />

updated and expanded brochure entitled “Basic Knowledge in Deburring<br />

Technology” in German and English.<br />

Further information, the entire exhibition portfolio and the<br />

complete agenda for the expert forum, as well as the provisional exhibitor<br />

list, can be found at www.deburring-expo.de.<br />

fairXperts GmbH & Co. KG<br />

D 72639 Neuffen<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 17/28


Romaco at PACK EXPO Las Vegas<br />

The new TPR 25 Pilot tablet coater<br />

The new TPR 25 Pilot tablet coater from Romaco Tecpharm will be unveiled to trade visitors at this year’s PACK EXPO Las<br />

Vegas. Romaco, the one stop solutions supplier for processing and packaging, will also be showing the PC 4350 high speed<br />

continuous motion cartoner from Romaco Promatic and the smart KTP 1X R&D tablet press from Romaco Kilian.<br />

Romaco will take advantage of this year’s PACK EXPO Las Vegas to<br />

present an exclusive selection of its processing and packaging technologies.<br />

The launch of the TPR 25 Pilot tablet coater underlines the<br />

one stop solutions supplier’s expertise in laboratory applications.<br />

From powder to pallet, the pharmaceutical machinery manufacturer<br />

has the right solution for every process step – either standalone or<br />

as an integrated line. Thereby, Romaco combines sustainability with<br />

cost efficiency: the energy, material and space savings achieved by<br />

Romaco machines reduce not only the end customer’s manufacturing<br />

costs but also their equipment’s carbon footprint.<br />

TPR 25 Pilot mobile tablet coater from Romaco Tecpharm for<br />

batch sizes from 5 to <strong>10</strong>0 percent<br />

Romaco Tecpharm is expanding its Optima product family with the<br />

TPR 25 Pilot mobile tablet coater. All inlet and exhaust airflow systems<br />

required for the coating process have been integrated into this<br />

compact pilot-scale unit for simple plug & play commissioning. As a<br />

modern all-in-one solution, its applications cover everything from<br />

development activities and scale-ups to the production of very small<br />

batches. The pilot coater is designed to handle batches weighing anything<br />

from 1 to 25 kg, making it suited for an extremely wide batch<br />

size range from 5 to <strong>10</strong>0 percent. The coating pan’s enormous flexibility<br />

is made possible by fully automated processes requiring no<br />

manual adjustments. The TPR 25 Pilot is equipped with Tecpharm’s<br />

patented Optima spray arm, which is controlled by a sonar system<br />

that automatically adjusts the distance between the spray gun and<br />

the tablet bed. Thanks to the spray arm’s intelligence, the coater<br />

does not have to be stopped and opened to correct the spray distance<br />

while the process is running. In addition to this, the extendable<br />

Optima spray arm has movable nozzles to ensure the ideal spray<br />

angle in any situation. The process air flowing through the tablet<br />

bed follows a precisely controlled path, which can be automatically<br />

adapted to the level in the drum with the aid of an exhaust flap that<br />

opens steplessly. This results in remarkably accurate application of<br />

the coating suspension and ultra-efficient drying of the tablet bed.<br />

From a sustainability viewpoint, Romaco Tecpharm’s TPR 25 Pilot<br />

consequently impresses with significantly shorter processing times<br />

coupled with lower energy and spray liquid consumption.<br />

PC 4350 continuous motion cartoner from Romaco Promatic<br />

with ophthalmic bottles feeding<br />

The PC 4350 high speed continuous motion cartoner from Romaco<br />

Promatic is designed for processing a very wide range of products.<br />

With its safe product handling concept, the cartoner is perfect for<br />

packaging extra-lightweight plastic bottles with small diameters and<br />

TPR 25 Pilot tablet coater from Romaco Tecpharm<br />

low filling volumes, such as those used for ophthalmics. A double conical<br />

wheel infeed system ensures safe transfer of the bottles to the<br />

cartoner even at the machine’s maximum speed. The machine can<br />

also be configured for feeding ecotrays with vials placed upright. Depending<br />

on the requirements, glass vials, tubes, strips, blisters, and<br />

countless other products can likewise be packaged quickly and reliably.<br />

The Promatic PC 4350 achieves a maximum output of 350 cartons<br />

per minute. Its positive carton opening system means there is<br />

no friction whatsoever, paving the way for gentle handling, especially<br />

where recycled cardboard is concerned. The GMP-compliant balcony<br />

design and ergonomic working height moreover speed up safe<br />

line clearance. The cartoner’s buckets are produced by 3D printing –<br />

an exciting first – so that material consumption during the manufacturing<br />

process is radically curtailed. Numerous anodized aluminum<br />

components and the recycled acrylic glass housing further reduce<br />

the cartoner’s carbon footprint. If required, Romaco Promatic’s PC<br />

4350 can be flexibly integrated into the diverse packaging concepts<br />

of the pharmaceutical, nutraceutical, cosmetics, food and chemical<br />

industries.<br />

KTP 1X R&D tablet press from Romaco Kilian with digital access<br />

to research data worldwide – ready for Industry 4.0<br />

The KTP 1X is the newest generation of Romaco Kilian’s R&D tablet<br />

presses for laboratory use. This single-stroke press was designed as<br />

an all-in-one instrument for research and development activities. It<br />

is suitable for pressing mono-layer, bi-layer and triple-layer tablets<br />

as well as tab-in-tab formats. Depending on the model, it achieves<br />

compression forces of up to 80 kN with a maximum output of 1800<br />

tablets per hour. This versatile R&D press enables the various tableting<br />

parameters, such as compression force or the possible tableting<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 18/28


speed, to be automatically determined. The smart measurement<br />

system evaluates huge amounts of data in next to no time for this<br />

purpose. The KTP 1X is moreover capable of simulating any standard<br />

rotary press, making it much easier to conduct scale-up trials.<br />

In addition to the production of clinical samples, the technology also<br />

allows detailed troubleshooting and hence supports process optimization.<br />

Thanks to the machine’s extremely good rigidity, the punch<br />

position in particular can now be measured more precisely. This high<br />

measuring accuracy goes hand in hand with extremely low product<br />

consumption, which is why the KTP 1X is not only very accurate but<br />

also cost-efficient and sustainable. Only a few test series are required<br />

to obtain meaningful results because the compression studies are<br />

highly automated. With its very small compaction area, the machine<br />

has a small footprint and is quick and easy to clean – for even greater<br />

time and energy savings. What’s more, the KTP 1X ships with a data<br />

module that gives users access to raw measurement data worldwide<br />

at any time, even when the tablet press is not in operation.<br />

Romaco Group<br />

D 76227 Karlsruhe<br />

Cleanroom microbiology specialists to discuss and highlight the best EM solutions for<br />

differing needs at key industry events<br />

Adviseing on reducing risk<br />

with EM in aseptic processing<br />

Cherwell, specialists in cleanroom microbiology solutions for the<br />

pharmaceutical, healthcare and related industries, will be available<br />

at a number of aseptic processing focused events in September to<br />

advise attendees on how they can reduce risk with environmental<br />

monitoring (EM). Cherwell’s microbial EM experts will be present<br />

at these events to discuss and highlight best practice and product<br />

solutions for differing EM needs to ensure the safety and quality of<br />

sterile medicinal products.<br />

The Company will be exhibiting at three key events, these are<br />

the PHSS Annual Conference in association with UCL Q3P <strong>2023</strong> (14<br />

September), the Aseptic Processing Conference (18-19 September),<br />

and the NHS QA - Quality Assurance and Technical Services Symposium<br />

(QATS) (28-29 September). In addition to offering advice,<br />

they will also be demonstrating a number of EM product solutions<br />

on Cherwell’s exhibition stand at each of these events, and how they<br />

can support contamination risk reduction in critical areas and processes<br />

in line with GMP Annex 1 requirements.<br />

Products available to view and discuss will include the new portable<br />

BAMS real-time, airborne microbial monitor for continuous air<br />

monitoring and instant alerts, particularly useful in GMP Grade A<br />

environments. Rapid identification enables prompt actions and reduces<br />

risk of potential contamination incidents. For active air sampling<br />

applications in lower grade cleanrooms, Cherwell will demonstrate<br />

the SAS hand held microbial air sampler range which offers<br />

reliable and cost-efficient sampling for trend analyses.<br />

High quality prepared culture media is also key for environmental<br />

monitoring applications for regulatory compliance. Cherwell’s<br />

Redipor® quality-assured prepared media range meets all needs<br />

for this traditional, reliable monitoring technique. Offering poured<br />

media plates, bottled media, broth bags, ampoules, and also tailored<br />

solutions, Cherwell will discuss how they can match the specific requirements<br />

of both organisation and facility.<br />

Cherwell will also highlight its EM accessories. These include<br />

Settle Plate stands offering a defined sample point and reducing the<br />

risk of a spoilt sample; plus plate carriers to aid safe handling and<br />

transportation, as well as efficient use of incubator space. SAS Daily<br />

Heads remove the need for a validated, sterilisation process and<br />

substitute this with a certificated sterile product which provides a<br />

viable alternative in the quest to reduce risk of false positives.<br />

“We find that attending events such as these is one of the best<br />

ways for us to keep up to speed with the very latest industry information<br />

on aseptic needs and best practices. We can learn from talks and<br />

presentations, plus discussions with delegates,” said Thomas Parkhill,<br />

Business Development Manager South, Cherwell. “It is also an<br />

ideal opportunity for us to be able to share and discuss our findings<br />

on good practice with our customers, and demonstrate how we and<br />

our product solutions can best support them in their use of EM to<br />

reduce risk in aseptic processing in line with Annex 1 requirements.”<br />

Alongside its microbial environmental product range, Cherwell<br />

also provides support in the area of risk reduction with EM through<br />

its Delivering Knowledge platform, specific Annex 1 resources, and<br />

by adopting a consultative sales approach that focuses on individual<br />

applications and product needs.<br />

Cherwell Laboratories Ltd<br />

OX26 4XB BICESTER<br />

United Kingdom<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 19/28


Process transparency and digital<br />

intelligence are factors for more sustainability<br />

The motan Group, Constance, is focusing its attention on minimizing energy consumption and the circular economy. At<br />

Fakuma from 17th to 21st October <strong>2023</strong>, in Friedrichshafen (Hall B1, Stand 1111), the materials management specialist will be<br />

presenting a selection of its energy-efficient ancillaries tailored to this purpose, as well as a CO2 calculator for assessing the<br />

carbon footprint when producing plastic parts. For processors in the medical and pharmaceutical industries, a completely<br />

new product line will be presented.<br />

„The energy data of the material have a massive influence on the<br />

overall ecological balance of the manufactured products. Plastics<br />

processors expect more transparency and standards here,“ explains<br />

CEO Sandra Füllsack. By means of energy monitoring, it is possible<br />

to record the energy consumption of each individual process step.<br />

The CO2 footprint of each individual part can be calculated, and<br />

the data is certified. This provides the processor with the basis for a<br />

systematic optimisation of the energy consumption of his individual<br />

production processes.<br />

Process-safe and energy-saving drying<br />

The material drying process is particularly energy intensive. In the<br />

latest generation of LUXOR SG small-volume dry air dryers, motan<br />

has incorporated the ecoPROTECT function as standard. Depending<br />

on the unit size, the function reduces energy consumption by<br />

<strong>10</strong>%. At the same time, the protective function ensures a secure and<br />

reliable drying without overor under-drying. The mobile small dryers,<br />

in which this process-safe technology has been combined with<br />

state-of-the-art microprocessor control, are among the trade fair<br />

highlights at the motan stand.<br />

FDA-compliant material conveying and gravimetric dosing<br />

and mixing<br />

motan has designed the new METRO G med material loaders especially<br />

for plastics processors in the medical and pharmaceutical industries.<br />

The extensive family of loaders are based on the established<br />

METRO G series of system loaders for plastic granulate and<br />

meet all strict hygiene requirements according to FDA 21 CFR. Spe-<br />

cial attention has been paid to process-safe use in all types of clean<br />

room. Special filters with high-quality FDA compliant seals and electropolished<br />

stainless steel surfaces ensure reliable, dust- and contaminationfree<br />

operation. A highlight is the new membrane implosion<br />

vacuum valve, which does not require compressed air.<br />

The gravimetric batch dosing and mixing unit GRAVICOLOR 1<strong>10</strong><br />

med is tailored to the same target group. Like the GRAVICOLOR 1<strong>10</strong><br />

introduced earlier this year, motan developed this new FDA-compliant<br />

version for flexible and reliable mixing and dosing in injection<br />

moulding, blow moulding and extrusion applications. Both systems<br />

can be seen on the exhibition stand. The dosing and mixing technology<br />

is identical. Specially developed vertical slide valves dose and<br />

mix up to four different components precisely and with the highest<br />

recipe accuracy. The integrated and improved IntelliBlend analysis<br />

function records the recipe, material and operating environment<br />

and documents all process data. With the help of this function, the<br />

user achieves continuous self-optimisation of the system and consequently<br />

the best possible operating point with the highest recipe<br />

accuracy and consistent, high product quality. Thanks to event-based<br />

logging, all parameter changes are stored in a control report and<br />

can be subsequently evaluated.<br />

Promoting a holistic understanding of the process<br />

Within the scope of the motan academy, companies can have their<br />

personnel trained to such an extent that not only the technology<br />

and function of individual units is understood, but also the entire<br />

production process. Being able to set up and operate a machine is<br />

important. Understanding how settings affect the entire process is<br />

even more important. The basic and advanced seminars of the motan<br />

academy teach users the interrelationships of material management<br />

in theory and practice.<br />

Plastic as a valuable material<br />

In a functioning circular economy with high-quality recycling, material<br />

handling plays a key role. To achieve this, motan focuses intensively<br />

on the digitalisation of systems and the networking of production<br />

processes. The avoidance of material or energy losses through<br />

appropriately designed systems is just one aspect that the material<br />

management specialist expresses with its slogan ‚Zero Loss‘. Continuously<br />

developing processes and products and making them more<br />

sustainable is part of motan‘s long-standing strategy. Fakuma, Europe‘s<br />

largest plastics trade fair, is an important signal. This is where<br />

the motan Group demonstrates how it is helping to shape the future<br />

of plastics.<br />

METRO G med – Medical material loaders for granulate (motan group)<br />

motan holding gmbh<br />

D 78467 Konstanz<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 20/28


Battery production in Europe takes off<br />

The energy and transport transition is in full swing. Support programmes and new regulations in Europe, the USA and<br />

especially China are fuelling a boom that has already clearly taken shape. The challenges are great, but so are the opportunities<br />

– also for the suppliers represented at POWTECH.<br />

„There are nine million bicycles in Beijing,“<br />

sings musician Katie Melua since 2005 - and<br />

she could now add: „and nine million electric<br />

cars in China.“ With a total of over five million<br />

new registrations in 2022, the nine million<br />

threshold was already exceeded last summer.<br />

And the trend is rapidly rising. Although government<br />

subsidies for electric vehicles have<br />

recently been cut even more in China than in<br />

Germany, this will not stop the trend towards<br />

electric cars. Buyers and manufacturers of<br />

vehicles with internal combustion engines<br />

are threatened with further trouble: while the<br />

new Euro 7 emissions standard is still being debated in Germany and<br />

Europe, China is demanding even stricter limits with regard to emissions<br />

from July <strong>2023</strong> with the 6b standard. It would be a scoundrel to<br />

think that the nation, which dominates the battery and thus the electric<br />

car market, will make the approval of new internal combustion<br />

vehicles, such as those offered by Western manufacturers, virtually<br />

impossible.<br />

This example highlights the current changes - and change hurts.<br />

There is hardly any other area of the economy where this can be observed<br />

as clearly as in the energy transformation: whether hydrogen,<br />

building heating, electric mobility or speed limits - the discussion<br />

about the best measures for a change in the energy and transport<br />

sector towards climate neutrality is causing sentiment to run high.<br />

And this could be just the beginning: More than 200 different energy<br />

transformation technologies are currently in various stages of market<br />

maturity. What they all have in common is that they are intended<br />

to help replace fossil fuels in the energy sector. And: the vast majority<br />

of them use climate-neutral electricity.<br />

50 battery factories to be built in Europe<br />

But there are enormous opportunities in this change. Companies<br />

that actively participate in the energy transformation will profit.<br />

Here, too, electromobility may serve as an example. In order to meet<br />

the massively increasing demand for batteries for electric vehicles,<br />

more than 50 battery factories are currently being planned in Europe<br />

alone. Because the production of batteries and battery materials<br />

is enormously demanding, plant and machine manufacturers are in<br />

demand who can develop these complex production processes and<br />

supply the equipment for them.<br />

The market for electrically powered vehicles is also growing rapidly,<br />

irrespective of stricter emission values, which in the long term<br />

can hardly be achieved by vehicles with combustion engines: In<br />

2022, the volume climbed by 50% to 425 billion US dollars compared<br />

to 2021. In the same period, the demand for batteries has doubled.<br />

And politicians are adding to the pressure: the „Net Zero Industry<br />

Act“ proposed by the European Union in March <strong>2023</strong> aims to have<br />

around 90% of the European Union‘s annual battery demand (550<br />

GWh) met by European battery manufacturers by 2030. In the United<br />

States, the Inflation Reduction Act provides billions of dollars<br />

in subsidies to build supply chains for electric vehicles, batteries<br />

© Michael Marais / Unsplash<br />

and battery minerals. Between August 2022<br />

and March <strong>2023</strong> alone, major electric vehicle<br />

and battery manufacturers have announced<br />

investments of at least $52 billion in North<br />

America, 50% of which will be for battery<br />

manufacturing, according to the IEA energy<br />

agency.<br />

Modern production technology in demand<br />

The new battery producers in Europe and elsewhere<br />

certainly have a chance to close the<br />

gap on the dominant battery nation China.<br />

After all, there is still a lot of potential for improvement in modern<br />

production technology to manufacture more powerful batteries at<br />

a lower price. Currently, alternatives to the lithium-ion battery are<br />

being developed in the form of lithium iron phosphate and sodium<br />

ion batteries, which have raw material and cost advantages. But there<br />

is also great potential for efficiency in the production of battery materials:<br />

mixing processes with a higher throughput and at the same<br />

time higher mixing quality are only one of many detailed aspects.<br />

And here, politics is also setting new framework conditions, such<br />

as the new EU regulations that have been in effect since May <strong>2023</strong><br />

and are intended to make the production, use and recycling of batteries<br />

more environmentally friendly. According to these regulations,<br />

at least 65% of all batteries must be recycled by 2025. The EU has set<br />

a binding target of 90% for the recovery of the metals cobalt, nickel<br />

and copper, which are essential for battery production. And the EU‘s<br />

Boundary Compensation Mechanism (CBAM) - possibly the most<br />

radical change yet for taxing greenhouse gas emissions - will also<br />

include precursor metals for batteries, including nickel. These specifications<br />

also offer opportunities - not only for recycling companies,<br />

but also for suppliers of processes and machinery.<br />

However, factory equipment - whether for the production of<br />

batteries or their recycling - is so far often still piecemeal. Often the<br />

proprietary manufacturing processes are planned down to the last<br />

detail by the operators themselves, which leads to problems at the<br />

interfaces between individual process steps, machines and their manufacturers.<br />

In addition, there are hardly any plant engineering companies<br />

that can build battery factories as EPC or EPCM contractors.<br />

Another complicating factor is the high requirements not only with<br />

regard to product quality but also operator protection: the materials<br />

used, often in powder form, are toxic and flammable and must be<br />

handled under hermetically sealed conditions (containment for hazard<br />

potential OEB 4 or OEB 5).<br />

The technologies for this are there - now it is a matter of clever<br />

cooperation between the actors and the will to implement. For<br />

example, it will be several years before the number of electric cars<br />

in Germany grows from the current one million to nine million. But<br />

„nine million electric bicycles“ is something we have already achieved<br />

on the way to climate neutrality in 2022, after all.<br />

NürnbergMesse GmbH<br />

D 90471 Nürnberg<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 21/28


The HTS801 sensor supports highly accurate measurement of humidity and temperature<br />

even under the most challenging conditions such as high humidity and chemical<br />

exposure.<br />

High-End Humidity and Temperature<br />

Sensor for Highest Demands<br />

The new HTS801 sees E+E Elektronik launch its most powerful humidity and temperature sensor for industrial applications<br />

on the market. This versatile, high-end measuring device combines the Austrian sensor specialist‘s decades of experience<br />

in the field of humidity measurement with the high quality demands of industrial metrology. The sensing probes of<br />

the HTS801 incorporate a premium, heatable sensing element for accurate measurements, guaranteeing long-term stability<br />

even under the most challenging conditions. Additional options such as a large colour display or plug-and-play probe<br />

replacement using rapidX technology ensure user-friendly operation and easy maintenance.<br />

Excellent Measuring Performance, Wide Range of Applications<br />

The HTS801 is particularly well suited to use in applications with<br />

high humidity and chemical exposure. It is based on the E+E sensing<br />

element with monolithic structure. An integrated heater enables targeted<br />

heating of the sensing element to prevent condensation and<br />

its negative impacts on the measurement results. Depending on the<br />

requirements, two type-specific operating modes are available for<br />

selection:<br />

– „Condensation Guard“ in case of a short-term risk<br />

of condensation<br />

– „High Humidity Guard“ for permanent exposure<br />

to high humidity and condensing conditions<br />

In addition to this, all HTS801 models have an Automatic ReCovery<br />

(ARC) function. ARC removes chemical impurities and eliminates<br />

possible drift effects through short-term intensive heating of the<br />

sensing element.<br />

Furthermore, the tried and trusted E+E sensor coating protects<br />

the sensing element and its leads against corrosion or deposits. This<br />

special coating extends the sensor‘s service life, ensuring<br />

accurate measurement results and improved long-term stability in<br />

harsh or corrosive environments.<br />

Thanks to its wide operating range from -80 °C to 180 °C (-112 °F<br />

to 356 °F) and 300 bar (4 351 psi), the HTS801 is suitable for a variety<br />

of applications; for example, for monitoring drying processes, humidity<br />

and temperature monitoring in fuel cell test benches, climate<br />

chambers or high-humidity storage rooms to demanding measurement<br />

tasks in meteorology and much more.<br />

The rugged polycarbonate or stainless-steel enclosure, featuring<br />

IP65 / NEMA 4X protection, supports easy mounting and maintenance<br />

of the HTS801.<br />

Plug-and-Play Probe Exchange<br />

The HTS801 offers the option of smart, pluggable sensing probes.<br />

Every HTS801 rapidX smart probe can be exchanged without configuration,<br />

adjustment or calibration following the plug-and-play<br />

principle. The specific parameters are stored directly in the probe<br />

and are transmitted to the sensor when the probe is plugged in. This<br />

avoids downtime and costs if a probe needs to be replaced due to<br />

damage or for recalibration.<br />

HTS801 humidity and temperature sensor for demanding industrial<br />

applications. (Photo: E+E Elektronik Ges.m.b.H.)<br />

HTS801 humidity and temperature sensor with stainless steel enclosure.<br />

(Photo: E+E Elektronik Ges.m.b.H.)<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 22/28


Display with Data Logging and Diagnostics Function<br />

The HTS801 is optionally available with a 3.5“ TFT colour display.<br />

This allows up to four physical quantities to be displayed simultaneously<br />

and monitored locally. The integrated data logging function<br />

stores up to 20 000 measured values per measurand. The values can<br />

be visualised on the display or downloaded using the USB service<br />

interface. Thanks to the on-board diagnostics function, the operating<br />

status of the HTS801 can be checked directly on the device.<br />

Interfaces and Configuration<br />

The measured data is available at two freely scalable analogue outputs,<br />

RS485 (Modbus RTU) or Ethernet PoE (Modbus TCP) interface,<br />

and at two alarm (relay) outputs. This enables flexible integration<br />

of the sensor into customer‘s own data acquisition systems.<br />

The HTS801 can be configured via the USB port using the free<br />

PCS<strong>10</strong> configuration software or directly on the device using the<br />

display and push-buttons.<br />

E+E Elektronik Ges.m.b.H.<br />

Langwiesen 7<br />

A 4209 Engerwitzdorf<br />

Telefon: +43 7235 6050<br />

Telefax: +43 7235 6058<br />

eMail: info@epluse.com<br />

Internet: http://www.epluse.com<br />

Reliable and Chemical-Restistant<br />

Long Lasting Labeling Solution<br />

for Laboratory Chair Manufacturer<br />

Schreiner ProTech‘s PolyScript label can master a whole range of challenges - especially when it comes to the special conditions<br />

in the laboratory sector. Recently, Cramer Inc., a Kansas City-based manufacturer of laboratory chairs, has also been<br />

relying on these identification labels from Schreiner.<br />

The PolyScript label permanently and reliably<br />

identifies Cramer Inc. laboratory chairs.<br />

Laboratory equipment, including chairs, must be robust, disinfectable, gapless, and<br />

antistatic. Cramer, which has specialized in special-purpose seating for nearly 90<br />

years, had been consistently encountering problems caused by the labels on its<br />

high-tech Helix® portfolio of lab chairs. Often, the labels either would fail to adhere<br />

properly – sometimes coming off as early as the assembly process – or vital printed<br />

information would be rendered illegible by the aggressive chemical cleaning agents<br />

common to lab settings. Without precise, reliable information pertaining to specific<br />

production batches, Cramer found it difficult to provide adequate technical aftersales<br />

support – a particularly concerning issue considering the company’s 15-year<br />

product warranties.<br />

Last year, Cramer and its long-time contract manufacturer, Michigan-based<br />

Nuvar Inc., adopted Schreiner ProTech’s Color Laser Films (CLFs), which reliably<br />

adhered to the chair frames and resisted the healthcare sector’s strict cleaning procedures.<br />

Unfortunately, the corresponding laser printer series was unexpectedly discontinued.<br />

A quick and uncomplicated solution was required. Pivoting, Schreiner<br />

ProTech suggested thermal transfer ribbon (TTR) printing, since the company had<br />

successfully employed similar solutions in the rugged industrial sectors it historically<br />

serves. In addition to providing exemplary ahdesion and withstanding harsh cleaning<br />

agents, the TTR-printed PolyScript labels could be printed with white lettering<br />

on a black background – a design perk for Cramer’s predominantly black chairs. “We<br />

almost exclusively manufacture black chairs, and don’t want a large, white sticker to<br />

take center stage on the back of the chair,” says Kyle Waggoner, Design Director for<br />

Cramer Inc. “The new label is coordinated in every detail and blends well with our<br />

holistic design initiatives for creating innovative and high-end laboratory seating<br />

furniture.”<br />

High-quality Helix® lab chairs equipped with Schreiner ProTech‘s durable Poly-<br />

Script labels - a promising combination that benefits users.<br />

Schreiner ProTech<br />

D 85764 Oberschleissheim<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 23/28


Arburg exhibit at Fakuma <strong>2023</strong><br />

Allrounder 520 A: Highly innovative<br />

IML application for medical technology<br />

– Innovative: In-mould labelling (IML) for centrifuge tubes creates added value<br />

– Integrated: IML labels increase functionality of medical technology products<br />

– In partnership: Joint project around high-performance electric machine<br />

Arburg will be present at Fakuma <strong>2023</strong> with nine exhibits on Stand 3<strong>10</strong>1 in Hall A3, plus ten additional machines on partner<br />

stands. While in-mould labelling (IML) is standard for packaging products, this process is still rarely used in the medical industry.<br />

Using centrifuge tubes with labels as an example, Arburg will be unveiling an innovative IML application with added<br />

value for the pharmaceutical industry and medical technology.<br />

Renowned partners KEBO (tooling), MCC/Verstraete (label), Beck<br />

(automation) and Intravis (camera inspection) are involved in the<br />

innovative joint IML project centred around an electric Allrounder<br />

520 A in clean room design.<br />

Functional integration using an IML label<br />

IML labels enable functional integration in a single step with no<br />

need for printing associated with rejects, for example, or further<br />

downstream work steps. As a result, the production process is fast,<br />

space-saving, cost-efficient and without any additional hygiene risk.<br />

The intelligent linking of data is essential for smooth digital communication<br />

between patients and doctors or home care applications.<br />

Individual codes can be used to track data on processes, quality and<br />

patients, for example, with <strong>10</strong>0 per cent traceability for each individual<br />

part. The monitoring of temperature profiles or information<br />

on recycling and warehouse management can also be implemented<br />

with these labels.<br />

High-performance electric machines for medical technology<br />

The exhibit, an electric Allrounder 520 A „Ultimate“ with 1,500 kN<br />

clamping force, is designed for fast and demanding processes such<br />

as thin-wall applications. The high-performance machine in clean<br />

room design meets the requirements of class ISO 7. An 8-cavity<br />

mould from KEBO is used to produce 15 millilitre tubes from PP. A<br />

label applicator head from Beck is used to apply the labels, while optical<br />

control is carried out via a camera system from Intravis. The servo-electric<br />

drives of the injection moulding machine ensure precise<br />

and reproducible mould positioning. With the exhibit, attention was<br />

also paid to a low carbon footprint, energy efficiency and a compact<br />

production cell.<br />

Expert Talks at Fakuma<br />

The project managers from Arburg, Beck, Intravis, Kebo and MCC<br />

will explain the advantages and potential of IML products for medical<br />

technology at two expert talks during the trade fair. These will<br />

take place on Wednesday 18 and Thursday 19 October, both at 2 p.m.<br />

in the “Schwarzwald” room, Conference Centre West.<br />

Registration:<br />

https://iml.mcclabel.com/en/expert-talks-at-fakuma<strong>2023</strong>.<br />

Further information:<br />

https://iml.mcclabel.com/en/medical-iml-at-fakuma<br />

ARBURG GmbH + Co KG<br />

D 72290 Loßburg<br />

An innovative application for medical technology is demonstrated by an electric Allrounder 520 A Ultimate. The high-performance machine will be<br />

producing IML centrifuge tubes at Fakuma <strong>2023</strong> as part of a joint project. (Photo: ARBURG)<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 24/28


Ingelfingen-based valve specialist GEMÜ is launching two new solutions for<br />

connecting single-use multi-port valve blocks.<br />

New solution for connecting<br />

multi-port valve blocks<br />

The first solution means that it is now possible<br />

to control the pneumatic locking of the<br />

valve block via locking cylinders thanks to a<br />

valve block sunk into the skid surface. The<br />

second solution consists of using a valve<br />

block placed onto the skid surface, where<br />

the valve body is manually connected to the<br />

actuator unit via a detachable hand lever.<br />

This second type offers greater flexibility for<br />

the spigot layout. The connection between<br />

the actuator and the diaphragms welded<br />

onto the valve block is created reliably wit-<br />

hin a few seconds using the familiar clamping<br />

principle of the GEMÜ SU40 SUMON-<br />

DO. The blocks themselves are produced by<br />

machining and can therefore be tailored to<br />

each specific application.<br />

There are several benefits to using single-use<br />

technology: Eliminating the need for<br />

conventional cleaning cycles and the associated<br />

costs for power, cleaning media, waste<br />

disposal and peripherals while increasing<br />

protection against cross contamination<br />

between different manufacturing drives.<br />

It also minimises downtimes in factories,<br />

which significantly improves the flexibility<br />

and effectiveness of single-use solutions in<br />

the medical and pharmaceutical technology<br />

sectors in comparison with conventional<br />

solutions. In addition, the use of single-use<br />

technology reduces negative environmental<br />

effects by eliminating energy-intensive<br />

cleaning cycles.<br />

Single-use multi-port valve block<br />

with manual locking device<br />

Single-use multi-port valve block<br />

with pneumatic locking device<br />

GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG<br />

D 74653 Ingelfingen<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Ausgabe DE 05-<strong>2023</strong> Seite 25/<strong>10</strong>3


EasyCare in use by customers<br />

Hygiene with precision<br />

In order to ensure long-term durability and performance of the tableting tools, a pharmaceutical-chemical company has<br />

opted for cleaning systems from the EasyCare range.<br />

The demands placed on tableting tools are<br />

continually increasing. “Our punches,<br />

segments and dies must be able to withstand<br />

enormous loads and be easy to replace<br />

and clean according to high hygiene<br />

standards,” explains Carmen Ackermann,<br />

Senior Product Manager at Fette Compacting.<br />

Companies that have been working with<br />

Fette Compacting for a long time know that the<br />

tableting tools from the company’s own production<br />

in Schwarzenbek are built precisely for such demands.<br />

However, it is also crucial how the tools are maintained throughout<br />

their entire product life cycle.<br />

One example: an international pharmaceutical and chemicals<br />

producer uses tablet presses and tableting tools from Fette Compacting<br />

at its main site. A main cleaning process is scheduled once a<br />

week for the machines and tools. In the past, this involved cleaning<br />

the tableting tools with the help of stock washers and, if necessary,<br />

manually. Trained technical supervisors then had to check the setup<br />

and cleaning steps individually. This was an altogether time-consuming<br />

process for which Fette Compacting, together with cooperation<br />

partners, has developed an efficient alternative called EasyCare.<br />

Handling and care go hand in hand<br />

EasyCare is a modular handling and care system for tableting tools.<br />

An important element is represented by the tool box system patented<br />

according to the TRI.EASY design principle, which allows punches,<br />

segments and dies to be transported, stored and cleaned in a<br />

protected manner. The trays of the cases fit exactly into a fully-automatic<br />

cleaning system of our partner ARUNA. In this so-called surge<br />

cleaning process, the tools are cleaned with cleaning and corrosion<br />

protection agents from Borer Chemie without leaving any residues.<br />

In addition, there is the option of automatic polishing, for which a<br />

machine from our partner nortec is available. Furthermore, the tool<br />

management system PartSite® enables simple system-supported<br />

management of tools and machine parts. With these Good Manufacturing<br />

Practice (GMP)- compliant-components, Fette Compacting<br />

offers a complete solution for the safe and efficient handling of<br />

tableting tools.<br />

Due to the general switch to fully-automatic cleaning in various<br />

areas of production, the pharmaceutical company decided to purchase<br />

two cleaning machines. During a visit to Schwarzenbek, the<br />

demonstration machine was thoroughly convincing. “Above all, the<br />

precise coordination between ARUNA and Fette Compacting in the<br />

design of the wash racks and the joint development of new components<br />

with optimized cleanability were decisive factors for the customer,”<br />

says Carmen Ackermann. “In the future, they want to have<br />

practically all machine parts reprocessed in the cleaning systems –<br />

even those that are currently still cleaned manually.”<br />

Shorter and easier cleaning<br />

ARUNA’s cleaning machines significantly reduce the cleaning time of<br />

machine parts and tableting tools while also saving space.<br />

Following conclusion of the validation phase, the new cleaning systems<br />

were commissioned in early <strong>2023</strong>. Several test runs had already<br />

been carried out to determine the recipe for punches and segments.<br />

The company expects that surge cleaning will shorten cleaning<br />

times and reduce the number of cleaning steps. The large loading<br />

volume and two-level wash racks offered by the machines significantly<br />

reduce the number of loading cycles.<br />

The producer of solid formulations is also testing the trays for<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 26/28


segments and bellows, whereby operators receive technical support<br />

from Fette Compacting.<br />

“Whether maintenance, troubleshooting, software updates or<br />

mechanical changes: service technicians from our partner company<br />

provide support at every step, training our customers’ staff and<br />

helping to optimize the cleaning process,” emphasizes Carmen<br />

Ackermann. And even more progress is in the pipeline: transport<br />

carts that can be lowered, thereby facilitating the loading process for<br />

employees are in the design phase at ARUNA. New storage racks<br />

could soon significantly reduce the space required for wash racks<br />

and transport carts. And thanks to EasyCare, the need for wash racks<br />

is already reduced, saving further space.<br />

Fette Compacting GmbH<br />

D 21493 Schwarzenbeck<br />

Clean Latches<br />

With parts to which hardly any dirt clings and that can be cleaned in place, there is less need to spend time and money on<br />

cleaning and cleaning media. This also translates into an increase in reliability for the production systems. With the latches<br />

GN 1150 in Hygienic Design, Ganter provides support for the machine and system cleaning concept known as clean in place,<br />

or CIP for short.<br />

Even outside of the industries that must traditionally comply with<br />

high standards of hygiene, the concept of clean in place, meaning<br />

the cleaning of components while still fully installed, is becoming<br />

ever more common. The idea is that if systems, fixtures or machines<br />

can be cleaned more easily and more quickly, this lowers the<br />

operating expenses in particular. This is why Ganter is continuously<br />

expanding its portfolio of standard parts in Hygienic Design (HD).<br />

The most recent HD standard part, GN 1150, refers to cam latches<br />

of stainless steel with special FDA-compliant seals of EPDM and<br />

TPU. Thanks to these seals, the latches have no dead spaces where<br />

dirt could collect. When the latch arm is turned by 90 degrees,<br />

its beveled surfaces produce a tension that reliably presses covers,<br />

hatches, doors or covers against their opposing element (frame or<br />

body). The rotational movement is currently achieved with a simple<br />

blue plastic key featuring a socket with two wrench surfaces, which<br />

is available as an accessory under the designation GN 1151. Additional<br />

drive types are currently under development.<br />

The standard part GN 1150 is itself available in two versions: The<br />

“front hygiene” version (FH) offers the HD standard on the actuation<br />

side, while the inside satisfies the typical requirements. Applications<br />

for this part include, for example, switch cabinets that must comply<br />

with hygiene requirements only on the outside.<br />

On the other hand, the “full hygiene” design (VH) features additional<br />

seals for HD quality even on the latch arm side.<br />

Both versions offer protection class IP 66 according to DIN <strong>EN</strong><br />

60529, meaning that they protect against the ingress of dust and<br />

heavy streams of water from any angle.<br />

The two standard parts are especially long-lasting thanks to a<br />

carefully developed design. The seals are also available in other materials<br />

upon request, allowing the parts to be adapted to customerspecific<br />

media exposures.<br />

Otto Ganter GmbH & Co. KG<br />

Triberger Straße 3<br />

D 78120 Furtwangen<br />

Telefon: +49 7723 65070<br />

Telefax: +49 7723 4659<br />

eMail: info@ganternorm.com<br />

Internet: http://www.ganternorm.com<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 27/28


For applications with flow rates up to 2000 l/h – Product Line Expansion<br />

Affordable Even at Higher Flow Rates:<br />

New pump sizes of the ecosmart<br />

diaphragm metering pump from<br />

LEWA combine low purchase cost<br />

with high performance<br />

In many applications in the chemical industry, the food industry and<br />

the oil and gas industry as well, pumps that work reliably and provide<br />

high performance are needed. At the same time, they must have<br />

convincingly low acquisition costs. With the ecosmart diaphragm<br />

metering pump, LEWA GmbH from Germany has provided a good<br />

value and safe model that can handle flow rates of up to <strong>10</strong>00 l/h. For<br />

use in applications with higher flow rates, the pump expert from Leonberg,<br />

Germany, is now expanding its product range with the new,<br />

powerful LCD variant. The model is designed for a flow rate of up to<br />

2000 l/h. The maximum permissible operating pressure is 50 bar or<br />

600 lbs. The stringent use of similar components within the ecosmart<br />

range keeps production costs and therefore, the final price, low.<br />

At the same time, a high level of safety can be guaranteed by focusing<br />

on all essential design features such as the pressure relief valve<br />

or the proven sandwich diaphragm with diaphragm monitoring. The<br />

LCD variant will be available from September <strong>2023</strong>.<br />

For this model, too, LEWA engineers were able to successfully<br />

implement the equal parts strategy they have often practiced. Pump<br />

users also benefit from this intelligent modular principle, as many<br />

wear parts can be used across pump types. This considerably simplifies<br />

the spare parts inventory. At the same time, the modular principle<br />

also allows individual adjustments to the respective application.<br />

For example, stroke frequencies or plunger diameters can be selected<br />

individually. The basis for this is the M900 pump head, which is<br />

already used in the LCA and LCC variants, as well as in the ecoflow<br />

program.<br />

Good integrability for plant construction companies<br />

The pump‘s flexibility also offers advantages for plant construction:<br />

For example, the ecosmart pump can be aligned either vertically or<br />

horizontally, making it easier to integrate the unit into systems with<br />

a very small footprint. In addition, the pump head of the new LCD<br />

variant is aligned at right angles to the plunger axis, resulting in a<br />

particularly compact format. In many pumps, the pump head is on<br />

the same axis as the plunger, which often results in bulky pump dimensions.<br />

The 90° orientation of the new models avoids this. This<br />

advantage is achieved by the extremely compact and completely redeveloped,<br />

cost-effective diaphragm drive.<br />

In order to ensure the long service life typical of LEWA pumps,<br />

only high-quality, robust materials are used in the LCD version. As<br />

with the other variants, the LCD complies with the U.S. metering<br />

pump API industry standard 675, so it can be used for numerous<br />

complex processes in a wide range of industries.<br />

LEWA ecosmart LCD in horizontal design (Source: LEWA GmbH)<br />

LEWA GmbH<br />

D 71229 Leonberg<br />

Impressum:<br />

cleanroom online / W.A. Schuster GmbH · Mozartstrasse 45 · D 70180 Stuttgart · Tel. +49 711 9 64 03 50 · Fax +49 711 9 64 03 66<br />

info@reinraum.de · www.cleanroom-online.de · GF Dipl.-Designer Reinhold Schuster · Stgt, HRB 14111 · VAT DE 147811997<br />

Original texts and images<br />

The contributions mentioned by name are the responsibility of the particular author. Reprinting, also of extracts, are permitted only with the approval of<br />

the editor and with reference to the source. The publisher does not accept any responsibility for unsolicited manuscripts and illustrations. The publisher<br />

is granted the exclusive, spatial, temporal and contentual limited right to freely use the article in unchanged or edited form for all purposes as often as<br />

desired or to transfer it to third parties for use. This right of use relates to print and electric media (Internet, databases, data carriers of all kinds).<br />

www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition <strong>EN</strong> <strong>10</strong>-<strong>2023</strong><br />

page 28/28

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!